Saggi Subodh J, Andoh Takeshi F, Safirstein Robert, Bennett William M
Division of Nephrology, Staten Island University Hospital, Staten Island, New York, USA.
Nephrology (Carlton). 2004 Apr;9(2):58-64. doi: 10.1111/j.1440-1797.2003.00230.x.
Chronic cyclosporin (CsA) administration has been shown to result in the replacement of epithelial cells in the kidney with fibrous tissue. These changes are kidney-specific, as they do not occur in any other organ.
Cyclosporin exposure increases c-fos and c-jun mRNA in the rat kidney but not in the liver. Furthermore, chronic CsA exposure causes a further increase in c-fos and c-jun mRNA and increases the renal expression of transforming growth factor-beta (TGF-beta) mRNA. These changes precede the development of fibrosis. The combined insult of ischaemia and CsA resulted in synergistic increases in c-fos, suggesting that CsA recruited a pathway for c-fos activation different from ischaemia. The calcium channel blocker, verapamil, blocked CsA-induced expression of c-fos and c-jun mRNA, and reduced the amount of TGF-beta expression.
These data are consistent with the notion that CsA induces protooncogenes, which may be, at least partially, responsible for long-term CsA nephrotoxicity.
长期给予环孢素(CsA)已被证明会导致肾脏中的上皮细胞被纤维组织取代。这些变化具有肾脏特异性,因为它们不会在任何其他器官中发生。
环孢素暴露会增加大鼠肾脏中c-fos和c-jun mRNA的水平,但不会增加肝脏中的水平。此外,长期暴露于CsA会导致c-fos和c-jun mRNA进一步增加,并增加转化生长因子-β(TGF-β)mRNA的肾脏表达。这些变化先于纤维化的发展。缺血和CsA的联合损伤导致c-fos协同增加,这表明CsA激活了一条不同于缺血的c-fos激活途径。钙通道阻滞剂维拉帕米可阻断CsA诱导的c-fos和c-jun mRNA表达,并减少TGF-β表达量。
这些数据与CsA诱导原癌基因的观点一致,这可能至少部分地导致了CsA的长期肾毒性。